Affordability
WHO recommends that countries use multiple pricing policies to achieve low prices for generic and biosimilar medicines. These policies may include internal reference pricing, mark up regulation, tendering and lower patient co payments.
WHO guideline on country pharmaceutical pricing policies
Promoting the use of quality assured generic and biosimilar medicines: WHO guideline on country pharmaceutical pricing policies. Plain language summary.